$GRBK
Green Brick Partners, Inc.

2013 Q3 Form 10-Q Financial Statement

#000114420413060249 Filed on November 12, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2012 Q4 2012 Q3
Revenue $0.00 -$378.4M $116.1M
YoY Change -100.0% -330.73% -28.52%
Cost Of Revenue $82.13M $124.2M
YoY Change -33.87% -20.13%
Gross Profit $20.85M -$8.043M
YoY Change -359.19% -214.9%
Gross Profit Margin -6.92%
Selling, General & Admin $1.000M -$1.100M $2.100M
YoY Change -52.38% -136.67% -16.0%
% of Gross Profit 4.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.830M $7.130M $6.806M
YoY Change 0.35% 1.57% -2.91%
% of Gross Profit 32.76%
Operating Expenses $1.000M -$402.3M $2.100M
YoY Change -52.38% -13510.0% -16.0%
Operating Profit -$1.049M -$1.166M -$1.432M
YoY Change -26.75% -118.22% -131.82%
Interest Expense $2.013M $1.901M
YoY Change 5.89% -195.05%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change
Pretax Income -$1.049M -$1.166M -$1.432M
YoY Change -26.75% -125.91% -157.28%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings $9.513M -$10.02M -$9.830M
YoY Change -196.78% -363.76% -546.82%
Net Earnings / Revenue -8.46%
Basic Earnings Per Share $0.86
Diluted Earnings Per Share $0.86 -$602.4K -$1.885M
COMMON SHARES
Basic Shares Outstanding 5.342M shares 5.224M shares
Diluted Shares Outstanding 5.342M shares 5.224M shares

Balance Sheet

Concept 2013 Q3 2012 Q4 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.30M $8.600M $10.80M
YoY Change 60.19% -43.05% 11.34%
Cash & Equivalents $17.30M $7.164M $10.84M
Short-Term Investments
Other Short-Term Assets $34.00K $0.00 $900.0K
YoY Change -96.22% -100.0% -70.0%
Inventory $11.19M $13.44M $12.90M
Prepaid Expenses $829.0K $126.0K
Receivables $7.237M $9.256M $13.90M
Other Receivables $0.00 $0.00
Total Short-Term Assets $38.54M $11.75M $38.50M
YoY Change 0.1% -79.38% -27.77%
LONG-TERM ASSETS
Property, Plant & Equipment $191.2M $106.0K $216.1M
YoY Change -11.54% -99.96% -10.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.775M $2.195M $2.000M
YoY Change 38.75% -21.61% -33.33%
Total Long-Term Assets $194.9M $2.301M $224.7M
YoY Change -13.25% -99.05% -10.9%
TOTAL ASSETS
Total Short-Term Assets $38.54M $11.75M $38.50M
Total Long-Term Assets $194.9M $2.301M $224.7M
Total Assets $233.5M $250.4M $263.2M
YoY Change -11.3% -16.41% -13.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.487M $27.00K $13.10M
YoY Change -65.75% -99.71% -18.63%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $170.6M $170.6M $170.5M
YoY Change 0.08% 1243.54% 1232.03%
Total Short-Term Liabilities $183.5M $163.0K $183.6M
YoY Change -0.08% -99.26% 535.29%
LONG-TERM LIABILITIES
Long-Term Debt $2.653M $2.789M $2.700M
YoY Change -1.74% -98.33% -98.41%
Other Long-Term Liabilities $2.943M $3.072M $10.60M
YoY Change -72.24% -71.02% -7.83%
Total Long-Term Liabilities $5.596M $6.000K $13.30M
YoY Change -57.92% -100.0% -92.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $183.5M $163.0K $183.6M
Total Long-Term Liabilities $5.596M $6.000K $13.30M
Total Liabilities $193.0M $195.3M $197.3M
YoY Change -2.17% -4.86% -8.36%
SHAREHOLDERS EQUITY
Retained Earnings -$129.1M
YoY Change
Common Stock $189.7M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.316M
YoY Change
Treasury Stock Shares 40.48K shares 40.48K shares
Shareholders Equity $43.55M $56.23M $65.90M
YoY Change
Total Liabilities & Shareholders Equity $233.5M $250.4M $263.2M
YoY Change -11.3% -16.41% -13.85%

Cashflow Statement

Concept 2013 Q3 2012 Q4 2012 Q3
OPERATING ACTIVITIES
Net Income $9.513M -$10.02M -$9.830M
YoY Change -196.78% -363.76% -546.82%
Depreciation, Depletion And Amortization $6.830M $7.130M $6.806M
YoY Change 0.35% 1.57% -2.91%
Cash From Operating Activities $7.090M -$1.270M $1.680M
YoY Change 322.02% -113.42% -72.09%
INVESTING ACTIVITIES
Capital Expenditures -$950.0K -$230.0K -$10.00K
YoY Change 9400.0% -70.13% -99.13%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$950.0K -$230.0K -$10.00K
YoY Change 9400.0% -70.13% -99.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -70.00K -20.00K -40.00K
YoY Change 75.0% -99.38% -98.77%
NET CHANGE
Cash From Operating Activities 7.090M -1.270M 1.680M
Cash From Investing Activities -950.0K -230.0K -10.00K
Cash From Financing Activities -70.00K -20.00K -40.00K
Net Change In Cash 6.070M -1.520M 1.630M
YoY Change 272.39% -127.69% 0.0%
FREE CASH FLOW
Cash From Operating Activities $7.090M -$1.270M $1.680M
Capital Expenditures -$950.0K -$230.0K -$10.00K
Free Cash Flow $8.040M -$1.040M $1.690M
YoY Change 375.74% -110.17% -76.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9323000 USD
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7237000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9256000 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
11192000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
13443000 USD
CY2013Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
1958000 USD
CY2012Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
3074000 USD
CY2013Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
829000 USD
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
882000 USD
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
34000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
78000 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
38540000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
36056000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
191154000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
209645000 USD
CY2013Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1001000 USD
CY2012Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1739000 USD
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2775000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
54000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
55110000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2983000 USD
CY2013Q3 us-gaap Assets
Assets
233470000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-15929000 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
233470000 USD
CY2012Q4 us-gaap Assets
Assets
250423000 USD
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4487000 USD
CY2013Q3 us-gaap Minority Interest
MinorityInterest
-3094000 USD
CY2012Q4 us-gaap Minority Interest
MinorityInterest
-1120000 USD
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40456000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11638000 USD
CY2013Q3 biof Long Term Debt Excluding Notes Issued Under Tax Increment Financing Current
LongTermDebtExcludingNotesIssuedUnderTaxIncrementFinancingCurrent
170642000 USD
CY2012Q4 biof Long Term Debt Excluding Notes Issued Under Tax Increment Financing Current
LongTermDebtExcludingNotesIssuedUnderTaxIncrementFinancingCurrent
170634000 USD
CY2013Q3 biof Tax Increment Financing Current
TaxIncrementFinancingCurrent
415000 USD
CY2012Q4 biof Tax Increment Financing Current
TaxIncrementFinancingCurrent
399000 USD
CY2013Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7906000 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2500000 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
183450000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
185171000 USD
CY2013Q3 biof Long Term Debt Excluding Notes Issued Under Tax Increment Financing Noncurrent
LongTermDebtExcludingNotesIssuedUnderTaxIncrementFinancingNoncurrent
2653000 USD
CY2012Q4 biof Long Term Debt Excluding Notes Issued Under Tax Increment Financing Noncurrent
LongTermDebtExcludingNotesIssuedUnderTaxIncrementFinancingNoncurrent
2795000 USD
CY2013Q3 biof Tax Increment Financing Noncurrent
TaxIncrementFinancingNoncurrent
3968000 USD
CY2012Q4 biof Tax Increment Financing Noncurrent
TaxIncrementFinancingNoncurrent
4275000 USD
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2943000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3072000 USD
CY2013Q3 us-gaap Liabilities
Liabilities
193014000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
195313000 USD
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
250423000 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
43550000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
56230000 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
79048000 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
116149000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
259119000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
378382000 USD
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
82132000 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
124192000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
266357000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
401204000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
-3084000 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
-8043000 USD
us-gaap Gross Profit
GrossProfit
-7238000 USD
us-gaap Gross Profit
GrossProfit
-22822000 USD
CY2013Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1040000 USD
CY2012Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1435000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
3439000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
4750000 USD
CY2013Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1527000 USD
CY2012Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
629000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
5252000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
2482000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5651000 USD
us-gaap Net Income Loss
NetIncomeLoss
-13221000 USD
us-gaap Net Income Loss
NetIncomeLoss
-29820000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-30054000 USD
CY2013Q3 us-gaap Other Income
OtherIncome
2535000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10107000 USD
CY2012Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1498000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1974000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5015000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-4461000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-9830000 USD
CY2012Q3 us-gaap Other Income
OtherIncome
680000 USD
us-gaap Other Income
OtherIncome
6590000 USD
us-gaap Other Income
OtherIncome
680000 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
2013000 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
1901000 USD
us-gaap Interest Expense
InterestExpense
5856000 USD
us-gaap Interest Expense
InterestExpense
5461000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5129000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11328000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15195000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34835000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q3 us-gaap Profit Loss
ProfitLoss
-5129000 USD
CY2012Q3 us-gaap Profit Loss
ProfitLoss
-11328000 USD
us-gaap Profit Loss
ProfitLoss
-15195000 USD
us-gaap Profit Loss
ProfitLoss
-34835000 USD
CY2013Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-668000 USD
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.84
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.88
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.48
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.76
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5342000 shares
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5224000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5331000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5178000 shares
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
99942000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1490000 USD
CY2012 biof Stock Issued During Period Value Exchange Of Class B Shares
StockIssuedDuringPeriodValueExchangeOfClassBShares
0 USD
CY2012 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2012 us-gaap Profit Loss
ProfitLoss
-46322000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
541000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1119000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21249000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21174000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2019000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
348000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2251000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-13271000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-53000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1248000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-7147000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
3725000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
5406000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
531000 USD
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5483773 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2717000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-948000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
3168000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10125000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2024000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
606000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2024000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-606000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
2000 USD
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
biof Repayments Of Debt Excluding Tax Increment Financing
RepaymentsOfDebtExcludingTaxIncrementFinancing
0 USD
biof Repayments Of Debt Excluding Tax Increment Financing
RepaymentsOfDebtExcludingTaxIncrementFinancing
6300000 USD
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
134000 USD
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
108000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-134000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6408000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7967000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4297000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15139000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10842000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
7000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
6000 USD
us-gaap Interest Paid
InterestPaid
315000 USD
us-gaap Interest Paid
InterestPaid
4180000 USD
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5483773 shares
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
40481 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
40481 shares
CY2012Q2 biof Reverse Stock Split Authorized Common Stock Ratio
ReverseStockSplitAuthorizedCommonStockRatio
On June 15, 2012, the Company effected a reverse stock split with respect to all outstanding shares of common stock and Class B common stock at a ratio of one-for-twenty.
CY2012Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
The Company also split the number of authorized shares of common stock at a ratio of one-for-fourteen, thereby reducing the aggregate number of authorized common stock shares to 10,000,000, and also split the number of authorized shares of Class B common stock at a ratio of one-for-twenty, thereby reducing the aggregate number of authorized Class B common stock shares to 3,750,000. All share and per share information and all necessary par value equity adjustments have been retroactively restated in the financial statements to reflect the effect of this reverse stock split.
biof Percentage Of Owned Of Subsidiaries Membership Units
PercentageOfOwnedOfSubsidiariesMembershipUnits
0.8730 pure
biof Remaining Percentage Of Owned By Investment Funds Affiliates
RemainingPercentageOfOwnedByInvestmentFundsAffiliates
0.1270 pure
biof Production Gallons Of Oil
ProductionGallonsOfOil
110000000 gal
CY2013Q3 us-gaap Debt Of Subsidiary Not Assumed
DebtOfSubsidiaryNotAssumed
9300000 USD
biof Operating Subsidiariespayment Terms
OperatingSubsidiariespaymentTerms
10.0 million contractual limit
CY2013Q3 us-gaap Escrow Deposit
EscrowDeposit
938000 USD
us-gaap Business Acquisition Equity Interest Issued Or Issuable Description
BusinessAcquisitionEquityInterestIssuedOrIssuableDescription
the Company would receive a full and final release of all known or potential claims of the lenders, as well as a 1% equity interest in Newco, which may be increased, under certain circumstances, to a 2% equity interest in Newco along with, in such circumstances, the right to acquire up to an additional 17.5% of the equity of Newco.
biof Potentially Dilutive Restricted Stock
PotentiallyDilutiveRestrictedStock
132519 shares
CY2013Q3 us-gaap Land Improvements
LandImprovements
19643000 USD
CY2012Q4 us-gaap Land Improvements
LandImprovements
19643000 USD
CY2013Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
49838000 USD
CY2012Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
49838000 USD
CY2013Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
250087000 USD
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
250042000 USD
CY2013Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
6499000 USD
CY2012Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
6493000 USD
CY2013Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
2266000 USD
CY2012Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
297000 USD
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
328333000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
326313000 USD
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
137179000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
116668000 USD
CY2013Q3 us-gaap Depreciation
Depreciation
6830000 USD
us-gaap Depreciation
Depreciation
20511000 USD
CY2012Q3 us-gaap Depreciation
Depreciation
6806000 USD
us-gaap Depreciation
Depreciation
20408000 USD
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5342064 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5224257 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5330887 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5177569 shares
CY2013Q3 biof Potentially Dilutive Class B Common Shares
PotentiallyDilutiveClassBCommonShares
795479 shares
CY2012Q3 biof Potentially Dilutive Class B Common Shares
PotentiallyDilutiveClassBCommonShares
869301 shares
biof Potentially Dilutive Class B Common Shares
PotentiallyDilutiveClassBCommonShares
795479 shares
biof Potentially Dilutive Class B Common Shares
PotentiallyDilutiveClassBCommonShares
908970 shares
CY2013Q3 biof Potentially Dilutive Restricted Stock
PotentiallyDilutiveRestrictedStock
101228 shares
CY2012Q3 biof Potentially Dilutive Restricted Stock
PotentiallyDilutiveRestrictedStock
146761 shares
biof Potentially Dilutive Restricted Stock
PotentiallyDilutiveRestrictedStock
112405 shares
CY2013Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
896707 shares
CY2012Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1016062 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
907884 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1041489 shares
CY2013Q3 biof Weighted Average Number Of Shares Outstanding Basic Including Potentially Dilutive Common Stock Equivalents
WeightedAverageNumberOfSharesOutstandingBasicIncludingPotentiallyDilutiveCommonStockEquivalents
6238771 shares
CY2012Q3 biof Weighted Average Number Of Shares Outstanding Basic Including Potentially Dilutive Common Stock Equivalents
WeightedAverageNumberOfSharesOutstandingBasicIncludingPotentiallyDilutiveCommonStockEquivalents
6240319 shares
biof Weighted Average Number Of Shares Outstanding Basic Including Potentially Dilutive Common Stock Equivalents
WeightedAverageNumberOfSharesOutstandingBasicIncludingPotentiallyDilutiveCommonStockEquivalents
6238771 shares
biof Weighted Average Number Of Shares Outstanding Basic Including Potentially Dilutive Common Stock Equivalents
WeightedAverageNumberOfSharesOutstandingBasicIncludingPotentiallyDilutiveCommonStockEquivalents
6219058 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5342064 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5224257 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5330887 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5177569 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
65481 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
71509 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Use of Estimates</font></i></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> Preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosures in the accompanying notes at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
240000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Concentrations of Credit Risk</font></i></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Credit risk represents the accounting loss that would be recognized at the reporting date if counterparties failed completely to perform as contracted. Concentrations of credit risk, whether on- or off-balance sheet, that arise from financial instruments exist for groups of customers or counterparties when they have similar economic characteristics that would cause their ability to meet contractual obligations to be similarly affected by changes in economic or other conditions described below.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> &#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the three and nine months ended September 30, 2013, the Operating Subsidiaries recorded sales to Cargill representing <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 76</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 75</font>%, respectively, of total net sales. During the three and nine months ended September 30, 2012, the Operating Subsidiaries recorded sales to Cargill representing <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 74</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 76</font>%, respectively, of total net sales. As of September 30, 2013 and December 31, 2012, the Operating Subsidiaries, had receivables from Cargill of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6.1</font> million and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7.5</font> million, respectively, representing <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 85</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 81</font>% of total accounts receivable, respectively.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Operating Subsidiaries purchase corn, its largest cost component in producing ethanol, from Cargill. During the three and nine months ended September 30, 2013, corn purchases from Cargill totaled $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">61.1</font> million and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">203.7</font> million, respectively. During the three and nine months ended September 30, 2012, corn purchases from Cargill totaled $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">95.4</font> million and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">310.8</font> million, respectively. As of September 30, 2013 and December 31, 2012, the Operating Subsidiaries, had payables to Cargill of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.8</font> million and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9.0</font> million, respectively, related to corn purchases.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
5902000 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
8198000 USD
CY2013Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
2096000 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2831000 USD
CY2013Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3194000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2414000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
704000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
8000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
8000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
8000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
33000 USD
us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
20 years
CY2013Q3 us-gaap Loans Payable Current
LoansPayableCurrent
170480000 USD
CY2012Q4 us-gaap Loans Payable Current
LoansPayableCurrent
170480000 USD
CY2013Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2466000 USD
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2475000 USD
CY2013Q3 us-gaap Notes Payable Current
NotesPayableCurrent
349000 USD
biof Subsidiaries Leasing Amount Per Year
SubsidiariesLeasingAmountPerYear
6700000 USD
CY2013Q3 biof Mileage Limit For Escalation Of Monthly Rental Charges
MileageLimitForEscalationOfMonthlyRentalCharges
30000 pure
CY2012Q4 us-gaap Notes Payable Current
NotesPayableCurrent
474000 USD
CY2013Q3 us-gaap Long Term Debt
LongTermDebt
173295000 USD
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
173429000 USD
CY2013Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
170642000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
170634000 USD
CY2013Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2653000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2795000 USD
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
170509000 USD
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
146000 USD
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
56000 USD
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
59000 USD
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
63000 USD
CY2013Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
2462000 USD
biof Management Fee Monthly
ManagementFeeMonthly
884000 USD
CY2012Q4 biof Management Fee Monthly
ManagementFeeMonthly
260000 USD
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.060 pure
CY2013Q3 biof Tax Increment Financing Debt Maturities Remainder Of Fiscal Year
TaxIncrementFinancingDebtMaturitiesRemainderOfFiscalYear
200000 USD
CY2013Q3 biof Tax Increment Financing Debt Maturities Repayments In Year Two
TaxIncrementFinancingDebtMaturitiesRepaymentsInYearTwo
431000 USD
CY2013Q3 biof Tax Increment Financing Debt Maturities Repayments In Year Three
TaxIncrementFinancingDebtMaturitiesRepaymentsInYearThree
464000 USD
CY2013Q3 biof Tax Increment Financing Debt Maturities Repayments In Year Four
TaxIncrementFinancingDebtMaturitiesRepaymentsInYearFour
501000 USD
CY2013Q3 biof Tax Increment Financing Debt Maturities Repayments In Year Five
TaxIncrementFinancingDebtMaturitiesRepaymentsInYearFive
540000 USD
CY2013Q3 biof Tax Increment Financing Debt Maturities Repayments After Year Five
TaxIncrementFinancingDebtMaturitiesRepaymentsAfterYearFive
2247000 USD
CY2013Q3 biof Tax Increment Financing Debt
TaxIncrementFinancingDebt
4383000 USD
CY2007Q1 biof Proceeds From Tax Increment Revenue Notes Issued
ProceedsFromTaxIncrementRevenueNotesIssued
6000000 USD
CY2007Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0785 pure
CY2007 biof Amount Available Under Stock Repurchase Plan
AmountAvailableUnderStockRepurchasePlan
7500000 USD
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
106.62
biof Amount Available Under Stock Repurchase Plan
AmountAvailableUnderStockRepurchasePlan
3184000 USD
CY2012Q2 biof Reverse Stock Split Outstanding Common Stock Ratio
ReverseStockSplitOutstandingCommonStockRatio
one-for-twenty
CY2013Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0 USD
CY2012Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-1957000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-3384000 USD
CY2013Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
141000 USD
CY2013Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0 USD
CY2012Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
219000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
90000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
710000 USD
CY2012Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
150000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
451000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
409000 USD
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
141000 USD
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
369000 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
71237 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5756 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
65481 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
65481 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
61.72
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
93.30
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
58.94
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
58.94
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y3M18D
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0.00 USD
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0.00 USD
CY2012Q4 biof Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsOutstandingNumber
10074 shares
biof Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsGranted
0 shares
biof Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Vested
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsVested
10074 shares
biof Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsForfeited
0 shares
CY2013Q3 biof Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsOutstandingNumber
0 shares
CY2012Q4 biof Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsWeightedAverageGrantDateFairValue
46.01
biof Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Granted Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsGrantedWeightedAverageGrantDateFairValue
0
biof Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Vested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsVestedWeightedAverageGrantDateFairValue
46.01
biof Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Forfeited Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2013Q3 biof Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsWeightedAverageGrantDateFairValue
0
CY2013Q3 biof Deferred Tax Assets Capitalized Start Up Costs
DeferredTaxAssetsCapitalizedStartUpCosts
2922000 USD
CY2012Q4 biof Deferred Tax Assets Capitalized Start Up Costs
DeferredTaxAssetsCapitalizedStartUpCosts
3253000 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
143026 shares
biof Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
41798 shares
biof Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expired In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod
0 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
101228 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
13.82
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
14.40
biof Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriodWeightedAverageGrantDateFairValue
0
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
13.58
CY2013Q3 biof Share Based Compensation Arrangement By Share Based Payments Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentsAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
369482 USD
CY2013Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1795000 USD
CY2012Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
3965000 USD
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
5318000 USD
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
12192000 USD
CY2013Q3 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
26000 USD
CY2012Q3 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
57000 USD
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
76000 USD
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
174000 USD
CY2013Q3 us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
237000 USD
CY2012Q3 us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
532000 USD
us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
701000 USD
us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
1780000 USD
CY2013Q3 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
1693000 USD
CY2012Q3 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
3736000 USD
us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
4650000 USD
us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
10519000 USD
CY2013Q3 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
109000 USD
CY2013Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
91034000 USD
CY2012Q3 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
246000 USD
us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-43000 USD
us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-67000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
8583000 USD
CY2011 biof Operating Lease Rent Expense Paid By Each Subsidiary Per Year
OperatingLeaseRentExpensePaidByEachSubsidiaryPerYear
4300000 USD
biof Changes In Equity From Net Income Loss Attributable To Parent And Transfers From Noncontrolling Interest
ChangesInEquityFromNetIncomeLossAttributableToParentAndTransfersFromNoncontrollingInterest
-13221000 USD
CY2013Q3 biof Deferred Lease Payments
DeferredLeasePayments
1500000 USD
CY2013Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2833000 USD
CY2013Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
965000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
965000 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
86913000 USD
CY2013Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-36000 USD
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-38000 USD
CY2013Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
94885000 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
91093000 USD
CY2013Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
52194000 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
47587000 USD
CY2013Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
42691000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
43506000 USD
CY2013Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
42691000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
43506000 USD
CY2013Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2013Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
255800000 USD
us-gaap Operating Loss Carryforwards Expiration Date
OperatingLossCarryforwardsExpirationDate
2028-12-31
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2013Q3 us-gaap Defined Benefit Plan Contributions By Plan Participants
DefinedBenefitPlanContributionsByPlanParticipants
33000 USD
us-gaap Defined Benefit Plan Contributions By Plan Participants
DefinedBenefitPlanContributionsByPlanParticipants
119000 USD
CY2012Q3 us-gaap Defined Benefit Plan Contributions By Plan Participants
DefinedBenefitPlanContributionsByPlanParticipants
50000 USD
us-gaap Defined Benefit Plan Contributions By Plan Participants
DefinedBenefitPlanContributionsByPlanParticipants
192000 USD
biof Description Of Employee Participation In Employee Benefit Plans
DescriptionOfEmployeeParticipationInEmployeeBenefitPlans
The LLC sponsors a 401(k) profit sharing and savings plan for its employees. Employee participation in this plan is voluntary and the LLC matches 50% of eligible employee contributions, up to an amount equal to 3% of employee compensation, on a biweekly basis.
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2852000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
8481000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
6972000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
6972000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
6972000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
5197000 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
37446000 USD
biof Changes In Equity From Net Income Loss Attributable To Parent And Transfers From Noncontrolling Interest
ChangesInEquityFromNetIncomeLossAttributableToParentAndTransfersFromNoncontrollingInterest
-29547000 USD
biof Percentage Of Minimum Annual Commissions Payable In Average Selling Price
PercentageOfMinimumAnnualCommissionsPayableInAverageSellingPrice
0.01 pure
CY2012Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2915000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
8554000 USD
biof Origination Fee Per Bushel Under Lease Agreements
OriginationFeePerBushelUnderLeaseAgreements
0.048
CY2013Q3 biof Minimum Annual Origination Fee Payable
MinimumAnnualOriginationFeePayable
1200000 USD
biof Number Of Gallons Of Ethanol
NumberOfGallonsOfEthanol
82500000 bbl
CY2013Q3 biof Deferred Ethanol Commissions
DeferredEthanolCommissions
1000000 USD
CY2013Q3 biof Minimum Ethanol Commissions Payable
MinimumEthanolCommissionsPayable
800000 USD
CY2013Q3 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
0 USD
CY2012Q3 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
227000 USD
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
0 USD
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
273000 USD
CY2013Q3 biof Changes In Equity From Net Income Loss Attributable To Parent And Transfers From Noncontrolling Interest
ChangesInEquityFromNetIncomeLossAttributableToParentAndTransfersFromNoncontrollingInterest
-4461000 USD
CY2012Q3 biof Changes In Equity From Net Income Loss Attributable To Parent And Transfers From Noncontrolling Interest
ChangesInEquityFromNetIncomeLossAttributableToParentAndTransfersFromNoncontrollingInterest
-9603000 USD
CY2007 biof Initial Public Offering Price Per Share
InitialPublicOfferingPricePerShare
210.00
CY2013Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.289 pure
biof Percentage Of Payment To Exchanging Llc Member In Cash Savings Under Tax Benefit Sharing Agreement
PercentageOfPaymentToExchangingLlcMemberInCashSavingsUnderTaxBenefitSharingAgreement
0.85 pure
biof Remaining Percentage Of Payment To Exchanging Llc Member In Cash Savings Under Tax Benefit Sharing Agreement
RemainingPercentageOfPaymentToExchangingLlcMemberInCashSavingsUnderTaxBenefitSharingAgreement
0.15 pure
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
65481 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
71509 shares

Files In Submission

Name View Source Status
0001144204-13-060249-index-headers.html Edgar Link pending
0001144204-13-060249-index.html Edgar Link pending
0001144204-13-060249.txt Edgar Link pending
0001144204-13-060249-xbrl.zip Edgar Link pending
biof-20130930.xml Edgar Link completed
biof-20130930.xsd Edgar Link pending
biof-20130930_cal.xml Edgar Link unprocessable
biof-20130930_def.xml Edgar Link unprocessable
biof-20130930_lab.xml Edgar Link unprocessable
biof-20130930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.gif Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v358642_10q.htm Edgar Link pending
v358642_ex31-1.htm Edgar Link pending
v358642_ex31-2.htm Edgar Link pending
v358642_ex32-1.htm Edgar Link pending
v358642_ex32-2.htm Edgar Link pending
v358642_ex99-1.htm Edgar Link pending